Exbio — Research products — Antibodies — CD and related antigens — Anti-Hu CD22 Purified Azide Free

Anti-Hu CD22 Purified Azide Free

Regulatory status

RUO

Antigen

CD22

Clone

IS7

Format

Purified Azide Free

Reactivity

Human

Application

FC (QC tested)

Variant

0.1 mg

10-506-C100

In stock

182.00 USD

0.025 mg

10-506-C025

Delivery 1 week

91.00 USD

Variant

0.1 mg

10-506-C100

In stock

182.00 USD

0.025 mg

10-506-C025

Delivery 1 week

91.00 USD

Contact distributor

Product details

Description

Images

References

SDS download

Isotype

Mouse IgG1

Specificity

The antibody IS7 reacts with an extracellular epitope of CD22 (BL-CAM), a 130 kDa type I transmembrane glycoprotein (immunoglobulin superfamily) expressed in the cytoplasm of pro-B and pre-B lymphocytes, and on the surface of mature and activated B lymphocytes; it is lost on plasma cells, peripheral blood T lymphocytes, granulocytes and monocytes.

Workshop

HLDA IV: WS Code B 227; HLDA V: WS Code B CD22.8

Application

FC (QC tested)

Application details

Flow cytometry: Recommended dilution: 1-4 µg/ml, Positive control: lysed whole blood; lyse-wash protocol

Reactivity

Human

Immunogen

human cell line Reh

Concentration

1 mg/ml

Preparation

Purified by protein-A affinity chromatography.

Formulation

Phosphate buffered saline (PBS), pH 7.4

Storage and handling

Store at 2-8°C. Do not freeze.

The product is intended For Research Use Only. Diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s.

Other names

SIGLEC2, SIGLEC-2

Antigen description

CD22, also known as Siglec-2 (sialic acid-binding immunoglobulin-like lectin-2) is a transmembrane glycoprotein binding alpha2,6-linked sialic acid-bearing ligands. Intracellular domain of CD22 recruits protein tyrosine phosphatase SHP-1 through the immunoreceptor tyrosine-based inhibitory motifs (ITIMs), thus setting a treshold for B cell receptor-mediated activation. CD22 also regulates B-cell response by involvement in controlling the CD19/CD21-Src-family protein tyrosine kinase amplification pathway and CD40 signaling. CD22 exhibits hallmarks of clathrin-mediated endocytic pathway.

Entrez Gene ID 933

UniProt ID P20273

Flow cytometry analysis (surface staining) of CD22 in human peripheral blood cells with anti-CD22 (IS7) azide free, GAM-APC.

General references:

Walker JA, Smith KG: CD22: an inhibitory enigma. Immunology. 2007 Dec 7
PubMed

Tateno H, Li H, Schur MJ, Bovin N, Crocker PR, Wakarchuk WW, Paulson JC: Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity. Mol Cell Biol. 2007 Aug;27(16):5699-710.
PubMed

Tedder TF, Poe JC, Haas KM: CD22: A Multifunctional Receptor That Regulates B Lymphocyte Survival and Signal Transduction. Adv Immunol. 2005;88:1-50.
PubMed